Form 4: Acacia Research Corp Director Maureen O'Connell Receives Stock Award

Sentiment:

SEC Form 4


Director Maureen O'Connell received 23,121 shares of Acacia Research Corp stock as part of the company's annual equity grant to non-employee directors.

Summary

  • On June 7, 2024, Maureen O'Connell, a director of Acacia Research Corp, was granted 23,121 shares of ACTG common stock.
  • This grant was part of the company's annual equity awards to non-employee directors, according to the 2024 Acacia Research Corporation Stock Incentive Plan.
  • The restricted stock will vest on the first anniversary of the grant date.
  • Following the transaction, O'Connell directly owns 240,431 shares of Acacia Research Corp.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant, which is generally viewed as a positive sign of aligning director interests with shareholders. There are no indications of negative news or concerns.

Positives

  • The grant of restricted stock aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements, but the equity grant suggests a continued commitment to incentivizing non-employee directors.

Industry Context

Equity grants to directors are a common practice in publicly traded companies to align their interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

  • Director compensation packages, including equity grants, vary significantly across industries and company sizes.
  • Comparing Acacia Research Corp's director compensation to similar technology licensing or intellectual property companies would provide a more relevant benchmark.
  • Companies like WiLAN or Marathon Patent Group could be considered for comparison, focusing on the size and structure of their director equity grants.

Stakeholder Impact

  • Shareholders may view the equity grant positively as it aligns the director's interests with the company's long-term performance.
  • The grant has a dilutive effect on existing shareholders, although the impact is likely minimal given the size of the grant.

Key Dates

DateDescription
06/07/2024Date of the stock grant to Maureen O'Connell
06/11/2024Date of the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.